Abstract

The present invention is directed to VEGF-2 polynucleotides and polypeptides and methods of using such polynucleotides and polypeptides. In particular, provided are methods of treating retinal disorders with VEGF-2 polynucleotides and polypeptides.


Claims
Download PDF
Document Preview
Document History
  • Publication: Apr 28, 2009
  • Application: Mar 14, 2005
    US US 7850705 A
  • Priority: Mar 14, 2005
    US US 7850705 A
  • Priority: Feb 7, 2000
    US US 49946800 A
  • Priority: Dec 22, 1999
    US US 17150599 P
  • Priority: Jun 3, 1999
    US US 13779699 P
  • Priority: Feb 12, 1999
    US US 11992699 P
  • Priority: Feb 8, 1999
    US US 11917999 P

Download Citation


Sign in to the Lens

Feedback